Back to Awarded Treatment Trials


Awarded Trial: 98-RC-325B-4

Grant ID

98-RC-325B-4

Illness

Bipolar Disorder

Primary Drug/Intervention

Risperidone

Primary Dosage

N/A

Secondary Drug Intervention

Olanzapine/Quetiapine

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Biederman

Sample Size

120

Duration of Study Period for Each Subject

8 weeks

Outcome Measurements

YMRS

Results

Children and adolescents, aged 7-18 received treatment with risperidone, olazapine or quetiapine for bipolar disoder. All three drugs were associated with a similar level of improvement. Olazapine was associated with a greater degree of weight gain.

Publication

N/A

Link

N/A

PI Name

Joseph Biederman

Degree

MD

Center

ADHD Program

Institution

Massachusetts General Hospital

Address

185 Alewife Brook Parkway, Suite 200

City or Town

Cambridge

State or Province

MA

Zip or Postal Code

2114

Country

USA

Email Address

biederman@helix.mgh.harvard.edu